Gordonmd Global Investments LP, 10% at Pyxis Oncology, Inc., Buys Shares Worth Undisclosed Amount

Pyxis Oncology, Inc. (PYXS) disclosed that Gordonmd Global Investments LP, who holds the position of 10% at the company, was involved in buying 5,517,000 shares, per a Form 4 filing with the SEC.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Company insiders are required to disclose changes in their stock ownership to the SEC on Form 4, typically within two business days of the trade.

Purchases by company insiders are one of several signals investors monitor, alongside earnings results and broader sector trends.